Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

International Stem Cell (ISCO) Total Debt (2016 - 2021)

Historic Total Debt for International Stem Cell (ISCO) over the last 13 years, with Q2 2021 value amounting to $476000.0.

  • International Stem Cell's Total Debt changed N/A to $476000.0 in Q2 2021 from the same period last year, while for Jun 2021 it was $476000.0, marking a year-over-year change of. This contributed to the annual value of $2.6 million for FY2020, which is 1037.97% up from last year.
  • As of Q2 2021, International Stem Cell's Total Debt stood at $476000.0.
  • Over the past 5 years, International Stem Cell's Total Debt peaked at $2.8 million during Q3 2017, and registered a low of $351000.0 during Q1 2018.
  • Over the past 5 years, International Stem Cell's median Total Debt value was $1.7 million (recorded in 2018), while the average stood at $1.5 million.
  • Its Total Debt has fluctuated over the past 5 years, first soared by 1047692.31% in 2017, then tumbled by 7310.34% in 2018.
  • International Stem Cell's Total Debt (Quarter) stood at $2.8 million in 2017, then tumbled by 36.55% to $1.7 million in 2018, then skyrocketed by 35.82% to $2.4 million in 2019, then increased by 10.38% to $2.6 million in 2020, then crashed by 81.8% to $476000.0 in 2021.
  • Its last three reported values are $476000.0 in Q2 2021, $1.1 million for Q1 2021, and $2.6 million during Q4 2020.